Professur für Dermatologie

DISEASE INTERCEPTION IN PSORIASIS PATIENTS WITH SUBCLINICAL JOINT INFLAMMATION BY INTERLEUKIN 17 INHIBITION WITH SECUKINUMAB - DATA FROM A PROSPECTIVE OPEN LABEL STUDY (2018) Kamoylafka E, Oliveira ID, Linz C, Lerchen V, Englbrecht M, Simon D, Sticherling M, et al. Conference contribution BRAF and MEK inhibitors change human immune cell phenotype and function; possible consequences for combination therapy (2018) Hoyer S, Eberlein V, Babalija L, Gerer K, Walter L, Schuler G, Schaft N, et al. Conference contribution Systemic therapy with calcitonin has positive clinical effects on systemic sclerosis in patients with cutaneous manifestations (2018) Uslu U, Streiff L, Sticherling M Journal article Prospective study in bullous pemphigoid: association of high serum anti-BP180 IgG levels with increased mortality and reduced Karnofsky score (2018) Holtsche MM, Goletz S, Van Beek N, Zillikens D, Benoit S, Harman K, Walton S, et al. Journal article High volume of polysorbate-containing (Tween® 80) solutions induces false-positive results in intradermal test (2018) Wagner N, Podda M Journal article FV03 MEK Inhibitors improved the Survival of NRAS-mutated Melanoma Patients by using Checkpoint Inhibitors: Results of a retrospective, multicenter Analysis of 364 Patients (2018) Kirchberger MC, Ugurel S, Mangana J, Heppt M, Eigentler T, Berking C, Schadendorf D, et al. Conference contribution From relative to absolute treatment outcomes-Correlation of PASI 90 and PASI <= 2 in three clinical trials with secukinumab (2018) Reich K, Bachhuber T, Melzer N, Sieder C, Sticherling M Conference contribution From relative to absolute Treatment Goals - Correlation of PASI 90 and PASI <=2 in three clinical Studies with Secukinumab (2018) Reich K, Bachhuber T, Melzer N, Sieder C, Sticherling M Conference contribution The p.Arg435His Variation of IgG3 With High Affinity to FcRn Is Associated With Susceptibility for Pemphigus Vulgaris-Analysis of Four Different Ethnic Cohorts (2018) Recke A, Konitzer S, Lemcke S, Freitag M, Sommer NM, Abdelhady M, Amoli MM, et al. Journal article Effective anti-programmed death-1 therapy in a SUFU-mutated patient with Gorlin-Goltz syndrome (2018) Moreira A, Kirchberger MC, Toussaint F, Erdmann M, Schuler G, Heinzerling L Journal article